EDGAR Filing Documents for 0001610618-24-000142

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001610618-24-000142

Filing Date

2024-11-07

Accepted

2024-11-07 16:08:31

Documents

Period of Report

2024-09-30

Document Format Files

Seq	Description	Document	Type	Size
1	CIDARA THERAPEUTICS, INC. FORM 10-Q	cdtx-20240930.htm iXBRL	10-Q	1669457
2	CERTIFICATION OF CEO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934	exhibit3112024-09.htm	EX-31.1	10382
3	CERTIFICATION OF CFO PURSUANT TO SECURITIES EXCHANGE ACT OF 1934	exhibit3122024-09.htm	EX-31.2	10365
4	CERTIFICATION OF CEO PURSUANT TO SARBANES-OXLEY ACT OF 2002	exhibit3212024-09.htm	EX-32.1	7862
5	CERTIFICATION OF CFO PURSUANT TO SARBANES-OXLEY ACT OF 2002	exhibit3222024-09.htm	EX-32.2	7888
11	GRAPHIC	cdtx-20240930_g1.jpg	GRAPHIC	436119
12	GRAPHIC	cdtx-20240930_g2.jpg	GRAPHIC	272194
13	GRAPHIC	cdtx-20240930_g3.jpg	GRAPHIC	457400
14	GRAPHIC	cdtx-20240930_g4.jpg	GRAPHIC	236043
	Complete submission text file	0001610618-24-000142.txt		11432685

Data Files

Seq	Description	Document	Type	Size
6	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	cdtx-20240930.xsd	EX-101.SCH	50164
7	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	cdtx-20240930_cal.xml	EX-101.CAL	86423
8	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	cdtx-20240930_def.xml	EX-101.DEF	337183
9	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	cdtx-20240930_lab.xml	EX-101.LAB	616109
10	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	cdtx-20240930_pre.xml	EX-101.PRE	492430
74	EXTRACTED XBRL INSTANCE DOCUMENT	cdtx-20240930_htm.xml	XML	1169443

Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121

Business Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121 858-752-6170

Cidara Therapeutics, Inc. (Filer) CIK: 0001610618 (see all company filings)